Unnatural Products Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
M&A
- (Announced)
- Latest Deal Amount
-
$1.15B
- Investors
-
29
Unnatural Products General Information
Description
Developer of a computational biology techniques platform designed to engineer peptides that access traditionally undruggable targets. The company's platform uses machine learning to create a parallel chemical synthesis that focuses on the rapid optimization of macrocyclic compounds by harnessing insights from nature, enabling researchers to accelerate the drug discovery process.
Contact Information
Website
www.unnaturalproducts.comCorporate Office
- 2161 Delaware Avenue
- Suite A
- Santa Cruz, CA 95060
- United States
Corporate Office
- 2161 Delaware Avenue
- Suite A
- Santa Cruz, CA 95060
- United States
Unnatural Products Timeline
Unnatural Products Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 09-Nov-2026 | $1.15B | Announced | Generating Revenue | ||
| 7. Later Stage VC (Series B) | 11-Feb-2026 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 19-Dec-2023 | Completed | Generating Revenue | |||
| 5. Seed Round | 03-Sep-2019 | Completed | Generating Revenue | |||
| 4. Seed Round | 02-Dec-2018 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
Unnatural Products Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 893,952 | $0.000010 | $0.24 | $0.24 | 1x | $0.24 | 0.23% | |
| Seed | 8,625,208 | $0.000010 | $0.72 | $0.72 | 1x | $0.72 | 2.2% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Unnatural Products Comparisons
Industry
Financing
Details
Unnatural Products Competitors (3)
One of Unnatural Products’s 3 competitors is Circle Pharma, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Circle Pharma | Venture Capital-Backed | South San Francisco, CA | ||||
| Oncodesign Services | Private Equity-Backed | Dijon, France | ||||
| PeptiDream | Formerly VC-backed | Kawasaki, Japan |
Unnatural Products Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Unnatural Products Patents
Unnatural Products Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3219980-A1 | Cell-permeable cyclic peptides and uses thereof | Pending | 26-May-2021 | ||
| EP-4351620-A1 | Cell-permeable cyclic peptides and uses thereof | Pending | 26-May-2021 | ||
| EP-4351620-A4 | Cell-permeable cyclic peptides and uses thereof | Pending | 26-May-2021 | ||
| JP-2024522093-A | Cell-permeable cyclic peptides and uses thereof | Pending | 26-May-2021 | ||
| US-20240199702-A1 | Cell-permeable cyclic peptides and uses thereof | Pending | 26-May-2021 | C07K7/64 |
Unnatural Products Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Unnatural Products Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Droia Ventures | Venture Capital | Minority | ||
| 10X Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Calm Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Unnatural Products FAQs
-
When was Unnatural Products founded?
Unnatural Products was founded in 2016.
-
Where is Unnatural Products headquartered?
Unnatural Products is headquartered in Santa Cruz, CA.
-
What is the size of Unnatural Products?
Unnatural Products has 50 total employees.
-
What industry is Unnatural Products in?
Unnatural Products’s primary industry is Drug Discovery.
-
Is Unnatural Products a private or public company?
Unnatural Products is a Private company.
-
What is the current valuation of Unnatural Products?
The current valuation of Unnatural Products is .
-
What is Unnatural Products’s current revenue?
The current revenue for Unnatural Products is .
-
How much funding has Unnatural Products raised over time?
Unnatural Products has raised $83.4M.
-
Who are Unnatural Products’s investors?
Droia Ventures, 10X Capital, , Calm Ventures, and are 5 of 29 investors who have invested in Unnatural Products.
-
Who are Unnatural Products’s competitors?
Circle Pharma, Oncodesign Services, and PeptiDream are competitors of Unnatural Products.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
